129,95 €
129,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
65 °P sammeln
129,95 €
129,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
65 °P sammeln
Als Download kaufen
129,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
65 °P sammeln
Jetzt verschenken
129,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
65 °P sammeln
  • Format: PDF

This book focuses on effective approaches to managing the challenging problem of co-morbidity of substance abuse with other disorders. Delivering cutting edge clinical research and data-driven treatment guidelines, this volume offers an integrative approach to treatment that targets both of the co-existing problems. Can mitigate the risk of relapse, and decrease symptom severity. This fully integrated approach provides a firm grounding for clinicians and researchers alike.
"This volume assembles the most expert of clinician-scientists who have dedicated their professional careers to
…mehr

Produktbeschreibung
This book focuses on effective approaches to managing the challenging problem of co-morbidity of substance abuse with other disorders. Delivering cutting edge clinical research and data-driven treatment guidelines, this volume offers an integrative approach to treatment that targets both of the co-existing problems. Can mitigate the risk of relapse, and decrease symptom severity. This fully integrated approach provides a firm grounding for clinicians and researchers alike.

"This volume assembles the most expert of clinician-scientists who have dedicated their professional careers to developing, delivering, evaluating, and disseminating integrated CBT for co-occurring emotional and substance use disorders...It is enthusiastically recommended for clinician education and training programs, researchers, and also frontline CBT therapists seeking to provide the best care possible to their complex patients."

- Mark McGovern, Professor, Department of Psychiatry, Department of Medicine, Stanford University School of Medicine

"Emotional disorders rarely occur in isolation, but most existing treatment protocols do not account for this. Comorbid substance use problems severely impact interventions that are ordinarily effective for anxiety and mood conditions. Dr. Wolitzky-Taylor tackles this problem head-on in this important book. Leading clinicians and scientists have provided clear and incisive recommendations that will inform beginning-level clinicians as well as experienced mental health professionals."

- N.B. Schmidt, Distinguished Research Professor and Chair, Department of Psychology, Florida State University; Director, Anxiety and Behavioral Health Clinic

"a groundbreaking volume that illuminates a vital shift in mental health care, confronting head on the historical divide between the separate treatment of emotional disorders and substance abuse. Offering a comprehensive, research-based roadmap for an integrated care model, this book challenges outdated treatment paradigms, advocating for simultaneous interventions. With contributions by leading experts, this volume is a timely resource, bridging the gap between research and practice, and empowering clinicians with practical strategies for addressing complex co-morbidity problems. It is essential reading for anyone committed to the highest quality of care."

- Jasper Smits, Ph.D., Professor, Department of Psychology, University of Texas at Austin


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Kate Wolitzky-Taylor, Ph.D., is a licensed clinical psychologist and Associate Professor in the UCLA Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior. With over 100 publications and continuous NIH funding for her research since her predoctoral training, she has extensive experience in the development, evaluation, and implementation of cognitive and behavioral therapies (CBT) for anxiety disorder and comorbid substance use disorders (SUD). Her research expertise was developed during her doctoral training in the Laboratory for the Study of Anxiety Disorders at the University of Texas at Austin, where she was funded by the National Institute of Mental Health (NIMH) on a National Research Service Award (F31) to examine the efficacy of self-administered treatments for pathological worry. She then completed her clinical internship at the Medical University of South Carolina, where she was funded on a NIMH training grant (T32) focusing on the research and treatment of trauma-related problems. She then completed a 3-year postdoctoral research fellowship in the Anxiety and Depression Research Center at UCLA, in which she was Project Director of a 10-year, multi-site, NIMH-funded longitudinal study examining common and specific risk factors for emotional disorders. She developed expertise in the nature and treatment of comorbid anxiety and SUD through her Early Career Development Award (K23) funded by the National Institute on Drug Abuse (NIDA), in which she developed and evaluated a CBT program for anxiety disorders to be delivered in SUD specialty clinics to those with comorbid anxiety and substance use disorders. Since then, she has received continuous funding for several NIH-funded studies aimed at developing and evaluating novel behavioral treatments for comorbid anxiety disorders and SUD. In addition to her innovative program of work in the treatment of comorbid anxiety and SUD, for which she received the Sobell Innovative Addictions Research Award from the Association for Behavioral and Cognitive Therapies, she is the Center co-Director for a NIMH-funded ALACRITY Center that aims to optimize a digitally-focused, tiered model of care for anxiety and depression among community college students. In addition to her research, she has an extensive history of providing clinical training and supervision to clinical psychology graduate students, postdoctoral fellows, psychiatry residents, and masters' level clinicians in CBT for anxiety disorders, depression, and comorbid emotional disorders and SUD. Dr. Wolitzky-Taylor also treats patients in the UCLA Faculty Practice, specializing in CBT for anxiety, depression, and comorbid emotional disorder/SUD treatment.